KHYMAZE TECHNOLOGIES LIMITED

Company number 09809530 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£600k -£400k -£200k £0 £200k £400k £600k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £5,526 Total assets 2017: £384,768 Total assets 2018: £581,241 Total assets 2019: £152,533 Total assets 2020: £217,873 Total assets 2021: £152,429 Total assets 2022: £141,847 Total assets 2023: £116,057 Total assets 2024: £141,055 Total assets 2025: £92,980 Total assets Net assets 2016: £2,762 Net assets 2017: £63,981 Net assets 2018: £116,073 Net assets 2019: £115,924 Net assets 2020: £132,113 Net assets 2021: £148,569 Net assets 2022: £72,758 Net assets 2023: £81,710 Net assets 2024: £76,095 Net assets 2025: £34,990 Net assets Total liabilities 2016: -£2,764 Total liabilities 2017: -£320,787 Total liabilities 2018: -£465,168 Total liabilities 2019: -£34,119 Total liabilities 2020: -£85,760 Total liabilities 2021: -£3,860 Total liabilities 2022: -£39,689 Total liabilities 2023: -£29,821 Total liabilities 2024: -£59,240 Total liabilities 2025: -£57,990 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 1 1 2 2 3 2024 2025 2024: 2 2025: 3

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 10 years

Latest accounts (2025-10-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-10-31 £92,980 -£57,990 £34,990 3
2024-10-31 £141,055 -£59,240 £76,095 2
2023-10-31 £116,057 -£29,821 £81,710
2022-10-31 £141,847 -£39,689 £72,758
2021-10-31 £152,429 -£3,860 £148,569
2020-10-31 £217,873 -£85,760 £132,113
2019-10-31 £152,533 -£34,119 £115,924
2018-10-31 £581,241 -£465,168 £116,073
2017-10-31 £384,768 -£320,787 £63,981
2016-10-31 £5,526 -£2,764 £2,762 £4,500

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.